FdaApplication
ANDA 202362
Identifiers
- fda_app_no: ANDA202362
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2014-05-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | ATOVAQUONE; PROGUANIL HYDROCHLORIDE | 250MG;100MG | TABLET;ORAL |
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | ATOVAQUONE; PROGUANIL HYDROCHLORIDE | 62.5MG;25MG | TABLET;ORAL |
2 products